首页> 外文期刊>ESC Heart Failure >ACE inhibitor-associated intestinal angioedema in orthotopic heart transplantation
【24h】

ACE inhibitor-associated intestinal angioedema in orthotopic heart transplantation

机译:ACE抑制剂相关性肠血管性水肿在原位心脏移植中的应用

获取原文
           

摘要

Abstract Angiotensin-converting enzyme inhibitor induced angioedema commonly involves the head and neck area. We report a case of angiotensin-converting enzyme inhibitor induced intestinal angioedema in a heart transplant recipient on mTOR immunosuppression. A 36-year-old Caucasian woman with history of heart transplantation on sirolimus, tacrolimus and prednisone presented to the Emergency Department with abdominal pain, one day following lisinopril initiation. A computer tomography scan demonstrated diffuse bowel wall thickening consistent with pancolitis and edema. She was subsequently diagnosed with angiotensin-converting enzyme inhibitor induced angioedema. Patients on mTOR immunosuppression are at higher risk for this potentially life-threatening side effect. Knowledge of this interaction is critical for providers prescribing mTOR agents.
机译:摘要血管紧张素转化酶抑制剂引起的血管性水肿通常累及头颈部。我们报告一例血管紧张素转换酶抑制剂诱导心脏移植受者mTOR免疫抑制引起的肠血管性水肿。赖诺普利启动后一天,一名患有西罗莫司,他克莫司和强的松心脏移植史的36岁白人妇女因腹痛出现在急诊科。计算机断层扫描显示肠壁弥漫性增厚,与胰腺炎和水肿一致。随后她被诊断出血管紧张素转化酶抑制剂引起的血管性水肿。接受mTOR免疫抑制的患者发生这种可能危及生命的副作用的风险更高。对于提供mTOR代理的提供商来说,这种交互作用的知识至关重要。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号